Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Preliminary Efficacy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05673538
What this trial is testing

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
TransThera Sciences (Nanjing), Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04089735
What this trial is testing

Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery

Who this might be right for
Ocular Inflammation and Pain After Cataract Surgery
Formosa Pharmaceuticals, Inc. 165
Early research (Phase 1)Looking for participantsNCT06469008
What this trial is testing

BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomasSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT05133076
What this trial is testing

Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications

Who this might be right for
Opioid-Induced Constipation
BioGaia Pharma AB 14
Testing effectiveness (Phase 2)Ended earlyNCT01838499
What this trial is testing

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
AstraZeneca 224
Early research (Phase 1)WithdrawnNCT05245916
What this trial is testing

IBI397 or Combination Therapies in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
Early research (Phase 1)Looking for participantsNCT07231120
What this trial is testing

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia

Who this might be right for
Cachexia-Anorexia SyndromeSolid Tumor Malignancies
Jiangsu Nutai Biologics Co., Ltd 54
Early research (Phase 1)Looking for participantsNCT06487624
What this trial is testing

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

Who this might be right for
Advanced Solid TumorRefractory Hodgkin Lymphoma
FBD Biologics Limited 50
Early research (Phase 1)Not Yet RecruitingNCT07468396
What this trial is testing

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Gan & Lee Pharmaceuticals. 65
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Early research (Phase 1)UnknownNCT05360368
What this trial is testing

HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Henlius Biotech 24
Not applicableStudy completedNCT05831813
What this trial is testing

The Feasibility, Acceptability and Preliminary Efficacy of a Group Intervention to Reduce Loneliness

Who this might be right for
LonelinessSocial Isolation
University of Amsterdam 9
Early research (Phase 1)Study completedNCT05364424
What this trial is testing

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Hoffmann-La Roche 43
Not applicableActive Not RecruitingNCT05958615
What this trial is testing

Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners

Who this might be right for
Obesity, Morbid
Larissa McGarrity, Ph.D. 82
Not applicableUnknownNCT01214590
What this trial is testing

Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy

Who this might be right for
Diabetic Neuropathy, Painful
VascuActive LTD 15
Not applicableStudy completedNCT02535923
What this trial is testing

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

Who this might be right for
InsomniaPsychosis
VA Office of Research and Development 47
Testing effectiveness (Phase 2)Looking for participantsNCT06938880
What this trial is testing

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Early research (Phase 1)Not Yet RecruitingNCT07778862
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors

Who this might be right for
Gynecological TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Looking for participantsNCT06321250
What this trial is testing

JMKX003948 Tablets in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma Metastatic
Jemincare 80
Testing effectiveness (Phase 2)Ended earlyNCT04750759
What this trial is testing

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat

Who this might be right for
Covid19
Charité Research Organisation GmbH 4
Next Page